Fibromyalgia

The word “gaslighting” has taken on a life of its own in recent years, being used in the context of interpersonal relationships, political discourse and online chatter alike.

ORLANDO — Medical cannabis is growing in acceptance and has benefits for managing pain in patients with rheumatic diseases, but more research is required, a presenter said at the 2022 Rheumatology Nurses Society Conference.

CHARLOTTE, N.C. — Study results indicate that better sleep efficiency in patients with fibromyalgia and insomnia may help improve their pain-related disability, according to a poster presented at the SLEEP meeting.

CHARLOTTE, N.C. — The use of morning light treatment in patients with fibromyalgia helped stabilize their sleep and led to improvements in pain and physical function, Helen J. Burgess, PhD, said at the SLEEP 2022 meeting.

High efficacy and acceptability were demonstrated in both on-label and off-label medications for fibromyalgia, reinforcing the value of symptom-based treatment plans, according to a study published in JAMA Network Open.

Myositis Awareness Month is focused on raising awareness and amplifying voices for patients with diseases falling under the myositis umbrella.

The FDA has granted De Novo authorization for NeuroMetrix to market its Quell neuromodulation device as an aid for reducing fibromyalgia symptoms in adults with high pain sensitivity, according to a company press release.

More than 40% of patients with long COVID experience “fibromyalgia-like,” multisite pain, according to data released by Tonix Pharmaceuticals.

A sublingual tablet form of the muscle relaxant cyclobenzaprine hydrochloride failed to achieve statistical significance in reducing fibromyalgia pain vs. placebo in a phase 3 trial, according to a press release.

Patients with long COVID can experience a constellation of debilitating neurological symptoms for months after infection, but the ‘underlying biology’ and a timeframe for these symptoms continue to elude clinicians, a presenter noted here.